Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Hui Cheng

10PUBLICATIONS
99CO-AUTHORS
Evolutionary computationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Artificial life and complex adaptive systemsHaematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|May 05, 2026
Engineered dCas12f1-SAM enables robust transcriptional activation and gain-of-function screening in primary human cells.

|Apr 28, 2025
Suppression of the Prostaglandin I2-Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction.

Huizhen Lv, Chenchen Wang, Zening Liu

|Jan 27, 2025
Advances in RNA editing in hematopoiesis and associated malignancies.

Shuangshuang Pu, Tao Cheng, Hui Cheng

|May 09, 2024
p21/Zbtb18 repress the expression of cKit to regulate the self-renewal of hematopoietic stem cells.

Nini Wang, Shangda Yang, Yu Li

|Feb 24, 2024
Ferritin-mediated mitochondrial iron homeostasis is essential for the survival of hematopoietic stem cells and leukemic stem cells.

Weiwei Yi, Jinhua Zhang, Yingxin Huang

|Feb 15, 2024
Cell softness renders cytotoxic T lymphocytes and T leukemic cells resistant to perforin-mediated killing.

Yabo Zhou, Dianheng Wang, Li Zhou

Pageof 2

Frequent Collaborators

5 joint publications

Tao Cheng

3 joint publications

Lai Guan Ng

2 joint publications

Liu Yang

2 joint publications

Keith Leong

2 joint publications

Ping Zhu

2 joint publications

Ye Chean Teh

2 joint publications

Ka Hang Liong

2 joint publications

Dehua Liu

2 joint publications

Yingrou Tan

2 joint publications

Melissa S F Ng

Frequent Collaborators

5 joint publications

Tao Cheng

3 joint publications

Lai Guan Ng

2 joint publications

Liu Yang

2 joint publications

Keith Leong

Top Related Videos

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on : Mar 29, 2019

9.6K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on : Jun 03, 2018

7.2K
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on : Oct 03, 2019

12.1K
See more related videos

Top Related Videos

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on : Mar 29, 2019

9.6K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on : Jun 03, 2018

7.2K
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on : Oct 03, 2019

12.1K
See more related videos